QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) All Versions of this Article: jpet.102.044628v1 305/3/872    most recent Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Zangar, R. C. Articles by Lee, D. W. Search for Related Content PubMed PubMed Citation Articles by Zangar, R. C. Articles by Lee, D. W.

CELLULAR AND MOLECULAR

Suppression of Cytochrome P450 3A Protein Levels by Proteasome Inhibitors

Pacific Northwest National Laboratory, Richland, Washington (R.C.Z., S.S., N.B., D.W.L.); Institute of Environmental Health Sciences, Wayne State University, Detroit, Michigan (T.A.K.); and School of Medicine, University of Missouri-Kansas City, Kansas City, Missouri (M.S.D.)

We have previously reported that CYP3A cross-links with polyubiquitinated proteins in microsomes from nicardipine-treated rats in a process that is distinct from classical polyubiquitination. To further examine the role of the proteasome in CYP3A degradation, we investigated the effects of proteasome inhibitors lactacystin, MG132, proteasome inhibitor 1, and hemin in primary cultures of rat and human hepatocytes. With the exception of hemin, these agents increased the total pool of ubiquitinated proteins in microsomes isolated from rat hepatocytes, indicating that lactacystin, MG132, and proteasome inhibitor 1 effectively inhibited the proteasome in these cells. All four agents caused a reduction in the amount of the major 55-kDa CYP3A band, opposite to what would be expected if the ubiquitin-proteasome pathway degraded CYP3A. Only hemin treatment caused an increase in high molecular mass (HMM) CYP3A bands. Because hemin treatment did not alter levels of ubiquitin in CYP3A immunoprecipitates, the HMM CYP3A bands formed in response to hemin treatment clearly were not due to proteasome inhibition. Rather, because hemin treatment also caused an increase in HMM CYP3A in the detergent-insoluble fraction of the 10,000g pellet, the HMM CYP3A seems to represent a large protein complex that is unlikely to primarily represent ubiquitination.

Address correspondence to: Richard C. Zangar, Pacific Northwest National Laboratory, 902 Battelle Blvd., MS P7-56, Richland, WA 99352. E-mail: richard.zangar{at}pnl.gov

This article has been cited by other articles:

				C.-M. Lee, J. Pohl, and E. T. Morgan Dual Mechanisms of CYP3A Protein Regulation by Proinflammatory Cytokine Stimulation in Primary Hepatocyte Cultures Drug Metab. Dispos., April 1, 2009; 37(4): 865 - 872. [Abstract] [Full Text] [PDF]

				R. C. Zangar, N. Bollinger, S. Verma, N. J. Karin, and Y. Lu The Nuclear Factor-{kappa}B Pathway Regulates Cytochrome P450 3A4 Protein Stability Mol. Pharmacol., June 1, 2008; 73(6): 1652 - 1658. [Abstract] [Full Text] [PDF]

				C. Lu, R. Gallegos, P. Li, C. Q. Xia, S. Pusalkar, V. Uttamsingh, D. Nix, G. T. Miwa, and L.-S. Gan INVESTIGATION OF DRUG-DRUG INTERACTION POTENTIAL OF BORTEZOMIB IN VIVO IN FEMALE SPRAGUE-DAWLEY RATS AND IN VITRO IN HUMAN LIVER MICROSOMES Drug Metab. Dispos., April 1, 2006; 34(4): 702 - 708. [Abstract] [Full Text] [PDF]